Cargando…

Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancer

Phosphatidylserine (PS) is a negatively charged phospholipid in all eukaryotic cells that is actively sequestered to the inner leaflet of the cell membrane. Exposure of PS on apoptotic cells is a normal physiological process that triggers their rapid removal by phagocytic engulfment under noninflamm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Belzile, Olivier, Huang, Xianming, Gong, Jian, Carlson, Jay, Schroit, Alan J, Brekken, Rolf A, Freimark, Bruce D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788995/ https://www.ncbi.nlm.nih.gov/pubmed/29417044 http://dx.doi.org/10.2147/ITT.S134834

Ejemplares similares

Antibody-mediated phosphatidylserine blockade significantly enhances the efficacy of downstream immune checkpoint inhibition in K1735 mouse melanoma
por: Huang, Xianming, et al.
Publicado: (2014)

Detection of phosphatidylserine-positive exosomes for the diagnosis of early-stage malignancies
por: Sharma, Raghava, et al.
Publicado: (2017)

Targeting phosphatidylserine synergizes with immune checkpoint blockade by inducing de novo tumor specific immunity
por: Huang, Xianming, et al.
Publicado: (2015)

Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment
por: Yopp, Adam, et al.
Publicado: (2014)

Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer
por: Birge, R B, et al.
Publicado: (2016)

Antibody targeting of phosphatidylserine for detection and immunotherapy of cancer
por: Zohar, Daniela Noa, et al.
Publicado: (2018)

Targeting of phosphatidylserine by monoclonal antibodies reverses an immunosuppressive checkpoint inducing innate and specific anti-tumor responses
por: Gong, Jian, et al.
Publicado: (2013)

Phosphatidylserine-targeting antibody induces M1 macrophage polarization, promotes myeloid derived suppressor cell differentiation and boosts tumor-specific immunity
por: Huang, Xianming, et al.
Publicado: (2013)

Targeting of phosphatidylserine by monoclonal antibodies enhances activity of immune checkpoint inhibitors in breast tumors
por: Gong, Jian, et al.
Publicado: (2014)

Targeting of phosphatidylserine by monoclonal antibodies augments the activity of paclitaxel and anti-PD1/PD-L1 therapy in the murine breast model E0771
por: Gray, Michael, et al.
Publicado: (2015)

TIMs, TAMs, and PS- antibody targeting: implications for cancer immunotherapy
por: Dayoub, Adam S., et al.
Publicado: (2020)

Detection of phosphatidylserine-positive exosomes as a diagnostic marker for ovarian malignancies: a proof of concept study
por: Lea, Jayanthi, et al.
Publicado: (2017)

Inhibiting Growth of Human Triple-Negative Breast Cancer Cells by Activating Mutant p53 Protein Alone or in Combination With a Phosphatidylserine-Targeting Antibody
por: Liang, Yayun, et al.
Publicado: (2021)

APR-246 alone and in combination with a phosphatidylserine-targeting antibody inhibits lung metastasis of human triple-negative breast cancer cells in nude mice
por: Liang, Yayun, et al.
Publicado: (2019)

Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers
por: Gray, Michael J., et al.
Publicado: (2016)

Identification of lipid-phosphatidylserine (PS) as the target of unbiasedly selected cancer specific peptide-peptoid hybrid PPS1
por: Desai, Tanvi J., et al.
Publicado: (2016)

SUN-LB055 Targeting Mutant p53 Alone or in Combination with a Phosphatidylserine Specific Antibody Suppresses Growth and Metastasis of Human Breast Cancer: A Strategy Towards Enhancing Personalized Medicine
por: Liang, Yayun, et al.
Publicado: (2019)

First-in-Man Evaluation of (124)I-PGN650: A PET Tracer for Detecting Phosphatidylserine as a Biomarker of the Solid Tumor Microenvironment
por: Laforest, Richard, et al.
Publicado: (2017)

Mobilizing phospholipids on tumor plasma membrane implicates phosphatidylserine externalization blockade for cancer immunotherapy
por: Wang, Weihong, et al.
Publicado: (2022)

Effective Binding of a Phosphatidylserine-Targeting Antibody to Ebola Virus Infected Cells and Purified Virions
por: Dowall, S. D., et al.
Publicado: (2015)

Hemolysis-associated phosphatidylserine exposure promotes polyclonal plasmablast differentiation
por: Vijay, Rahul, et al.
Publicado: (2021)

Targeting phosphatidylserine for Cancer therapy: prospects and challenges
por: Chang, Wenguang, et al.
Publicado: (2020)

Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles()
por: Blanco, Victor M., et al.
Publicado: (2015)

Phosphatidylserine targeting for diagnosis and treatment of human diseases
por: Schutters, Kristof, et al.
Publicado: (2010)

Conditional targeting of phosphatidylserine decarboxylase to lipid droplets
por: Kumar, Santosh, et al.
Publicado: (2021)

Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies
por: Radin, Massimo, et al.
Publicado: (2020)

Anti-Phosphatidylserine/Prothrombin Antibodies Are Associated with Adverse Pregnancy Outcomes
por: Žigon, Polona, et al.
Publicado: (2015)

Induction of Immune Responses and Phosphatidylserine Exposure by TLR9 Activation Results in a Cooperative Antitumor Effect with a Phosphatidylserine-targeting Prodrug
por: Tseng, Jen-Chih, et al.
Publicado: (2023)

Phosphatidylserine-targeted liposome for enhanced glioma-selective imaging
por: Zhang, Liang, et al.
Publicado: (2016)

Optical and nuclear imaging of glioblastoma with phosphatidylserine-targeted nanovesicles
por: Blanco, Víctor M., et al.
Publicado: (2016)

Anti-Phosphatidylserine-Prothrombin Antibodies are Associated with Outcome in a TIA Cohort
por: Mullen, Michael T., et al.
Publicado: (2012)

Antibodies against Native and Oxidized Cardiolipin and Phosphatidylserine and Phosphorylcholine in Atherosclerosis Development
por: Frostegård, Anna G., et al.
Publicado: (2014)

Phosphatidylserine synthase 2 and phosphatidylserine decarboxylase are essential for aminophospholipid synthesis in T rypanosoma brucei
por: Farine, Luce, et al.
Publicado: (2017)

Targeting the Phosphatidylserine-Immune Checkpoint with a Small-Molecule Maytansinoid Conjugate
por: Lo, Chen-Fu, et al.
Publicado: (2022)

Highly Specific PET Imaging of Prostate Tumors in Mice with an Iodine-124-Labeled Antibody Fragment That Targets Phosphatidylserine
por: Stafford, Jason H., et al.
Publicado: (2013)

Phosphatidylserine-Targeted Nanotheranostics for Brain Tumor Imaging and Therapeutic Potential
por: Wang, Lulu, et al.
Publicado: (2017)

TAM receptors, Phosphatidylserine, inflammation, and Cancer
por: Burstyn-Cohen, Tal, et al.
Publicado: (2019)

Anti-Phosphatidylserine/Prothrombin Antibodies in Healthy Women with Unexplained Recurrent Pregnancy Loss
por: Pleguezuelo, Daniel E., et al.
Publicado: (2021)

Phosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumors
por: Blanco, Víctor M., et al.
Publicado: (2014)

The effect of phosphatidylserine on golf performance
por: Jäger, Ralf, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_cfve4irc44lkdnid9kv68j2k8c